Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

Ly-49L Inhibitors

The chemicals listed above are not direct inhibitors of Ly-49L but can indirectly influence its function or expression. Ly-49L, being a member of the killer cell lectin-like receptor subfamily, plays a significant role in the immune response, particularly in the activities of natural killer (NK) cells. The absence of direct chemical inhibitors for Ly-49L necessitates the consideration of compounds that modulate immune responses or NK cell functions, as these can have downstream effects on Ly-49L. Most of these compounds are immunomodulatory agents or kinase inhibitors. For example, Cyclosporin A and Tacrolimus, both immunosuppressive agents, inhibit calcineurin, an enzyme crucial for T-cell activation. Although their primary action is on T-cells, the resulting modulation of the immune system can have indirect effects on NK cells and their receptors, including Ly-49L. Similarly, kinase inhibitors like Sunitinib, Sorafenib, Imatinib, and Dasatinib affect various signaling pathways that are essential for the proliferation, activation, and survival of different immune cells, including NK cells. By altering these pathways, they may impact the expression or the functional state of Ly-49L.

Proteasome inhibitors like Bortezomib and immunomodulatory drugs such as Lenalidomide and Thalidomide also play a role. These compounds influence the immune system's functionality, potentially affecting NK cell behavior and indirectly the role of Ly-49L. Lastly, immune checkpoint inhibitors like Nivolumab and Pembrolizumab, primarily used in cancer therapy, can modulate the immune response. This modulation can affect the activity of NK cells, thereby indirectly influencing Ly-49L. In summary, while direct chemical inhibitors of Ly-49L are not available, the aforementioned compounds provide an indirect approach to modulate the protein's function or expression. Their actions on various pathways in the immune system offer insights into how Ly-49L activity might be influenced in the context of immune response and NK cell functionality.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Cyclosporin A

59865-13-3sc-3503
sc-3503-CW
sc-3503A
sc-3503B
sc-3503C
sc-3503D
100 mg
100 mg
500 mg
10 g
25 g
100 g
$63.00
$92.00
$250.00
$485.00
$1035.00
$2141.00
69
(5)

Cyclosporin A is an immunosuppressive agent that inhibits calcineurin. By doing so, it can indirectly influence Ly-49L expression or function in NK cells.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Sirolimus, also known as rapamycin, is an mTOR inhibitor. It indirectly affects NK cell functions, potentially influencing Ly-49L-related pathways.

FK-506

104987-11-3sc-24649
sc-24649A
5 mg
10 mg
$78.00
$151.00
9
(1)

Tacrolimus inhibits calcineurin like Cyclosporin A, affecting T-cell activation and potentially influencing NK cell function and Ly-49L expression.

Sunitinib, Free Base

557795-19-4sc-396319
sc-396319A
500 mg
5 g
$153.00
$938.00
5
(0)

Sunitinib is a receptor tyrosine kinase inhibitor, which may affect the signaling pathways in NK cells, indirectly influencing Ly-49L functionality.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

Sorafenib targets multiple kinases and might influence NK cell-mediated immune responses, thereby indirectly affecting Ly-49L.

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$26.00
$119.00
$213.00
27
(1)

Imatinib is a tyrosine kinase inhibitor, primarily known for its effect in certain leukemias, and could indirectly influence pathways related to Ly-49L in NK cells.

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$70.00
$145.00
51
(1)

Dasatinib is another tyrosine kinase inhibitor which could modulate the activity of NK cells, indirectly affecting Ly-49L.

Lenalidomide

191732-72-6sc-218656
sc-218656A
sc-218656B
10 mg
100 mg
1 g
$50.00
$374.00
$2071.00
18
(1)

Lenalidomide modulates the immune system and could indirectly influence Ly-49L expression or activity in NK cells.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Bortezomib is a proteasome inhibitor and can affect NK cell function, thereby potentially influencing Ly-49L.

Thalidomide

50-35-1sc-201445
sc-201445A
100 mg
500 mg
$111.00
$357.00
8
(0)

Thalidomide, with immunomodulatory properties, might impact NK cell activity and indirectly affect Ly-49L expression or function.